Secretory phospholipase A2-IIa, a potential biomarker for prostate cancer, is regulated by the HER/HER2-elicited pathway

被引：0
|
作者：
Oleksowicz, Leslie
Liu, Yin [1 ]
Bracken, R. Bruce
Gaitonde, Krishnanath
Burke, Barbara
Succop, Paul
Levin, Linda
Dong, Zhongyun
Lu, Shan [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH 45237 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2011年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
296
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [21] Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032
    Kitadokoro, K
    Hagishita, S
    Sato, T
    Ohtani, M
    Miki, K
    JOURNAL OF BIOCHEMISTRY, 1998, 123 (04): : 619 - 623
  • [22] Serum amyloid A, phospholipase A2-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases
    Menschikowski, Mario
    Hagelgans, Albert
    Fuessel, Susanne
    Mareninova, Olga A.
    Asatryan, Liana
    Wirth, Manfred P.
    Siegert, Gabriele
    INFLAMMATION RESEARCH, 2013, 62 (12) : 1063 - 1072
  • [23] Secretory phospholipase A2-IIA (sPLA2-IIA) activity and concentration in human tears and correlation with the ocular surface disease index (OSDI) scores.
    Panthi, Shyam
    Nichols, Jason J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Serum amyloid A, phospholipase A2-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases
    Mario Menschikowski
    Albert Hagelgans
    Susanne Fuessel
    Olga A. Mareninova
    Liana Asatryan
    Manfred P. Wirth
    Gabriele Siegert
    Inflammation Research, 2013, 62 : 1063 - 1072
  • [25] Limits of Mendelian Randomization Analyses in Selection of Secretory Phospholipase A2-IIA as a Valid Therapeutic Target for Prevention of Cardiovascular Disease
    Rosenson, Robert S.
    Hurt-Camejo, Eva
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (09) : 942 - 943
  • [26] Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer
    Wang, M.
    Hao, F-Y.
    Wang, J-G.
    Xiao, W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (18) : 2648 - 2654
  • [27] Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade
    Graff, JR
    Konicek, BW
    Deddens, JA
    Chedid, M
    Hurst, BM
    Colligan, B
    Neubauer, BL
    Carter, HW
    Carter, JH
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 3857 - 3861
  • [28] In silico investigation of the molecular effects caused by R123H variant in secretory phospholipase A2-IIA associated with ARDS
    Righino, Benedetta
    Minucci, Angelo
    Pirolli, Davide
    Capoluongo, Ettore
    Conti, Giorgio
    De Luca, Daniele
    De Rosa, Maria Cristina
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 81 : 68 - 76
  • [29] HER2 as a potential therapeutic target on quiescent prostate cancer cells
    Yumoto, Kenji
    Rashid, Jibraan
    Ibrahim, Kristina G.
    Zielske, Steven P.
    Wang, Yu
    Omi, Maiko
    Decker, Ann M.
    Jung, Younghun
    Sun, Dan
    Remmer, Henriette A.
    Mishina, Yuji
    Buttitta, Laura A.
    Taichman, Russell S.
    Cackowski, Frank C.
    TRANSLATIONAL ONCOLOGY, 2023, 31
  • [30] Evaluation of Her2 RNA expression as a potential predictive biomarker for anti-Her2 therapy
    Lamb, Laura E.
    Khazanov, Nickolay A.
    Hovelson, Daniel H.
    Kwiatkowski, Kat
    Johnson, D. Bryan
    Rhodes, Daniel R.
    Tomlins, Scott A.
    CANCER RESEARCH, 2023, 83 (07)
12345